Bochner BH - Search Results

1

Clements MB, Beech BB, Atkinson TM, Dalbagni GM, Li Y, Vickers AJ, Herr HW, Donat SM, Sjoberg DD, Tin AL, Coleman JA, Rapkin BD, Laudone VP, Bochner BH. Clements MB, et al. Among authors: bochner bh. J Urol. 2023 May;209(5):910. doi: 10.1097/JU.0000000000003201.02. Epub 2023 Mar 6. J Urol. 2023. PMID: 36876406 No abstract available.

2

Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.

Bochner BH, Herr HW, Reuter VE. Bochner BH, et al. J Urol. 2001 Dec;166(6):2295-6. J Urol. 2001. PMID: 11696756

3

Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Herr HW, et al. Among authors: bochner bh. J Urol. 2002 Mar;167(3):1295-8. J Urol. 2002. PMID: 11832716

4

Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence.

Yossepowitch O, Dalbagni G, Golijanin D, Donat SM, Bochner BH, Herr HW, Fair WR, Russo P. Yossepowitch O, et al. Among authors: bochner bh. J Urol. 2003 Jan;169(1):177-81. doi: 10.1016/S0022-5347(05)64062-1. J Urol. 2003. PMID: 12478130

5

Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.

Holzbeierlein JM, Lopez-Corona E, Bochner BH, Herr HW, Donat SM, Russo P, Dalbagni G, Sogani PC. Holzbeierlein JM, et al. Among authors: bochner bh. J Urol. 2004 Sep;172(3):878-81. doi: 10.1097/01.ju.0000135530.59860.7d. J Urol. 2004. PMID: 15310988

6

Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping.

Bochner BH, Cho D, Herr HW, Donat M, Kattan MW, Dalbagni G. Bochner BH, et al. J Urol. 2004 Oct;172(4 Pt 1):1286-90. doi: 10.1097/01.ju.0000137817.56888.d1. J Urol. 2004. PMID: 15371825

7

Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.

Mullerad M, Russo P, Golijanin D, Chen HN, Tsai HH, Donat SM, Bochner BH, Herr HW, Sheinfeld J, Sogani PC, Kattan MW, Dalbagni G. Mullerad M, et al. Among authors: bochner bh. J Urol. 2004 Dec;172(6 Pt 1):2177-81. doi: 10.1097/01.ju.0000144505.40915.98. J Urol. 2004. PMID: 15538226

8

Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract.

Raj GV, Bochner BH, Vickers A, Teper E, Lin O, Donat SM, Herr H, Dalbagni G. Raj GV, et al. Among authors: bochner bh. J Urol. 2006 Jun;175(6):2038-41; discussion 2041. doi: 10.1016/S0022-5347(06)00279-5. J Urol. 2006. PMID: 16697796

9

Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.

Dash A, Galsky MD, Vickers AJ, Serio AM, Koppie TM, Dalbagni G, Bochner BH. Dash A, et al. Among authors: bochner bh. Cancer. 2006 Aug 1;107(3):506-13. doi: 10.1002/cncr.22031. Cancer. 2006. PMID: 16773629 Free article.

10

Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.

Yossepowitch O, Eggener SE, Bochner BH, Donat SM, Herr HW, Dalbagni G. Yossepowitch O, et al. Among authors: bochner bh. J Urol. 2006 Aug;176(2):482-5. doi: 10.1016/j.juro.2006.03.066. J Urol. 2006. PMID: 16813873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters